抗消化性潰瘍薬の世界市場2020-2026:プロトンポンプ阻害剤(PPI)、カリウム競合性酸遮断薬(P-CAB)、制酸薬、H2拮抗薬、抗生物質、潰瘍保護薬

QYResearchが発行した調査報告書(QYR20AP00098)
◆英語タイトル:Global Anti Peptic Ulcer Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00098
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、抗消化性潰瘍薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗消化性潰瘍薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(プロトンポンプ阻害剤(PPI)、カリウム競合性酸遮断薬(P-CAB)、制酸薬、H2拮抗薬、抗生物質、潰瘍保護薬)、用途別市場規模(胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症(GERD))、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗消化性潰瘍薬の種類別市場2015-2026:プロトンポンプ阻害剤(PPI)、カリウム競合性酸遮断薬(P-CAB)、制酸薬、H2拮抗薬、抗生物質、潰瘍保護薬
・抗消化性潰瘍薬の用途別市場2015-2026:胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症(GERD)
・抗消化性潰瘍薬の北米市場分析
・抗消化性潰瘍薬のアジア市場分析
・抗消化性潰瘍薬の中南米市場分析
・抗消化性潰瘍薬の中東・アフリカ市場分析
・関連企業情報:Eisai、Daewoong Pharmaceutical、Takeda Pharmaceutical、HeliCure、AstraZeneca、Ore Pharmaceuticals、Sihuan Pharmaceutical、GlaxoSmithKline、Pfizer、Abbott Laboratories、Yuhan Corporation、Cadila Healthcare、Boehringer Ingelheim
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Anti Peptic Ulcer Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti Peptic Ulcer Drugs.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti Peptic Ulcer Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti Peptic Ulcer Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti Peptic Ulcer Drugs market. Readers of the report can become informed about current and future trends of the global Anti Peptic Ulcer Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti Peptic Ulcer Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti Peptic Ulcer Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti Peptic Ulcer Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti Peptic Ulcer Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti Peptic Ulcer Drugs market is segmented into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs

Market Segment by Application, the Anti Peptic Ulcer Drugs market is segmented into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

This report includes the following manufacturers; we can also add the other companies as you want.
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim

The study objectives are:
To analyze and research the global Anti Peptic Ulcer Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti Peptic Ulcer Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti Peptic Ulcer Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti Peptic Ulcer Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti Peptic Ulcer Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Proton Pump Inhibitors (PPIs)
1.3.3 Potassium-Competitive Acid Blockers (P-CAB)
1.3.4 Antacids
1.3.5 H2 Antagonists
1.3.6 Antibiotics
1.3.7 Ulcer Protective Drugs
1.4 Market Segment by Application
1.4.1 Global Anti Peptic Ulcer Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Gastritis
1.4.3 Gastric Ulcers
1.4.4 Duodenal Ulcers
1.4.5 Gastroesophageal Reflux Disease (GERD)
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti Peptic Ulcer Drugs Revenue (2015-2026)
2.1.1 Global Anti Peptic Ulcer Drugs Revenue (2015-2026)
2.1.2 Global Anti Peptic Ulcer Drugs Sales (2015-2026)
2.2 Anti Peptic Ulcer Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti Peptic Ulcer Drugs Sales by Regions (2015-2020)
2.2.2 Global Anti Peptic Ulcer Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anti Peptic Ulcer Drugs Regions (Countries) Ranking by Market Size
2.4 Anti Peptic Ulcer Drugs Industry Trends
2.4.1 Anti Peptic Ulcer Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti Peptic Ulcer Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti Peptic Ulcer Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti Peptic Ulcer Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anti Peptic Ulcer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti Peptic Ulcer Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti Peptic Ulcer Drugs Sales in 2019
3.2 Global Top Manufacturers Anti Peptic Ulcer Drugs by Revenue
3.2.1 Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti Peptic Ulcer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Peptic Ulcer Drugs as of 2019)
3.4 Global Anti Peptic Ulcer Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti Peptic Ulcer Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti Peptic Ulcer Drugs Market
3.7 Key Manufacturers Anti Peptic Ulcer Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti Peptic Ulcer Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anti Peptic Ulcer Drugs Price by Type (2015-2020)
4.1 Global Anti Peptic Ulcer Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti Peptic Ulcer Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anti Peptic Ulcer Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anti Peptic Ulcer Drugs Price Forecast by Type (2021-2026)

5 Global Anti Peptic Ulcer Drugs Market Size by Application
5.1 Global Anti Peptic Ulcer Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anti Peptic Ulcer Drugs Price by Application (2015-2020)
5.2 Global Anti Peptic Ulcer Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti Peptic Ulcer Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anti Peptic Ulcer Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anti Peptic Ulcer Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti Peptic Ulcer Drugs Breakdown Data by Company
6.2 North America Anti Peptic Ulcer Drugs Breakdown Data by Type
6.3 North America Anti Peptic Ulcer Drugs Breakdown Data by Application
6.4 North America Anti Peptic Ulcer Drugs Breakdown Data by Countries
6.4.1 North America Anti Peptic Ulcer Drugs Sales by Countries
6.4.2 North America Anti Peptic Ulcer Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti Peptic Ulcer Drugs Breakdown Data by Company
7.2 Europe Anti Peptic Ulcer Drugs Breakdown Data by Type
7.3 Europe Anti Peptic Ulcer Drugs Breakdown Data by Application
7.4 Europe Anti Peptic Ulcer Drugs Breakdown Data by Countries
7.4.1 Europe Anti Peptic Ulcer Drugs Sales by Countries
7.4.2 Europe Anti Peptic Ulcer Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti Peptic Ulcer Drugs Breakdown Data by Company
8.2 Asia Pacific Anti Peptic Ulcer Drugs Breakdown Data by Type
8.3 Asia Pacific Anti Peptic Ulcer Drugs Breakdown Data by Application
8.4 Asia Pacific Anti Peptic Ulcer Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anti Peptic Ulcer Drugs Sales by Regions
8.4.2 Asia Pacific Anti Peptic Ulcer Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti Peptic Ulcer Drugs Breakdown Data by Company
9.2 Latin America Anti Peptic Ulcer Drugs Breakdown Data by Type
9.3 Latin America Anti Peptic Ulcer Drugs Breakdown Data by Application
9.4 Latin America Anti Peptic Ulcer Drugs Breakdown Data by Countries
9.4.1 Latin America Anti Peptic Ulcer Drugs Sales by Countries
9.4.2 Latin America Anti Peptic Ulcer Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti Peptic Ulcer Drugs Breakdown Data by Type
10.2 Middle East and Africa Anti Peptic Ulcer Drugs Breakdown Data by Application
10.3 Middle East and Africa Anti Peptic Ulcer Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anti Peptic Ulcer Drugs Sales by Countries
10.3.2 Middle East and Africa Anti Peptic Ulcer Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Eisai
11.1.1 Eisai Corporation Information
11.1.2 Eisai Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Eisai Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Eisai Anti Peptic Ulcer Drugs Products and Services
11.1.5 Eisai SWOT Analysis
11.1.6 Eisai Recent Developments
11.2 Daewoong Pharmaceutical
11.2.1 Daewoong Pharmaceutical Corporation Information
11.2.2 Daewoong Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Products and Services
11.2.5 Daewoong Pharmaceutical SWOT Analysis
11.2.6 Daewoong Pharmaceutical Recent Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Corporation Information
11.3.2 Takeda Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Products and Services
11.3.5 Takeda Pharmaceutical SWOT Analysis
11.3.6 Takeda Pharmaceutical Recent Developments
11.4 HeliCure
11.4.1 HeliCure Corporation Information
11.4.2 HeliCure Business Overview and Total Revenue (2019 VS 2018)
11.4.3 HeliCure Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 HeliCure Anti Peptic Ulcer Drugs Products and Services
11.4.5 HeliCure SWOT Analysis
11.4.6 HeliCure Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.5.3 AstraZeneca Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 AstraZeneca Anti Peptic Ulcer Drugs Products and Services
11.5.5 AstraZeneca SWOT Analysis
11.5.6 AstraZeneca Recent Developments
11.6 Ore Pharmaceuticals
11.6.1 Ore Pharmaceuticals Corporation Information
11.6.2 Ore Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Products and Services
11.6.5 Ore Pharmaceuticals SWOT Analysis
11.6.6 Ore Pharmaceuticals Recent Developments
11.7 Sihuan Pharmaceutical
11.7.1 Sihuan Pharmaceutical Corporation Information
11.7.2 Sihuan Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Products and Services
11.7.5 Sihuan Pharmaceutical SWOT Analysis
11.7.6 Sihuan Pharmaceutical Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Anti Peptic Ulcer Drugs Products and Services
11.8.5 GlaxoSmithKline SWOT Analysis
11.8.6 GlaxoSmithKline Recent Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Pfizer Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Pfizer Anti Peptic Ulcer Drugs Products and Services
11.9.5 Pfizer SWOT Analysis
11.9.6 Pfizer Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Corporation Information
11.10.2 Abbott Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Abbott Laboratories Anti Peptic Ulcer Drugs Products and Services
11.10.5 Abbott Laboratories SWOT Analysis
11.10.6 Abbott Laboratories Recent Developments
11.11 Yuhan Corporation
11.11.1 Yuhan Corporation Corporation Information
11.11.2 Yuhan Corporation Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Yuhan Corporation Anti Peptic Ulcer Drugs Products and Services
11.11.5 Yuhan Corporation SWOT Analysis
11.11.6 Yuhan Corporation Recent Developments
11.12 Cadila Healthcare
11.12.1 Cadila Healthcare Corporation Information
11.12.2 Cadila Healthcare Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Cadila Healthcare Anti Peptic Ulcer Drugs Products and Services
11.12.5 Cadila Healthcare SWOT Analysis
11.12.6 Cadila Healthcare Recent Developments
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Corporation Information
11.13.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Boehringer Ingelheim Anti Peptic Ulcer Drugs Products and Services
11.13.5 Boehringer Ingelheim SWOT Analysis
11.13.6 Boehringer Ingelheim Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti Peptic Ulcer Drugs Sales Channels
12.2.2 Anti Peptic Ulcer Drugs Distributors
12.3 Anti Peptic Ulcer Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.1.1 Global Anti Peptic Ulcer Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.2.2 North America Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anti Peptic Ulcer Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anti Peptic Ulcer Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti Peptic Ulcer Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anti Peptic Ulcer Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti Peptic Ulcer Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti Peptic Ulcer Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti Peptic Ulcer Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Eisai、Daewoong Pharmaceutical、Takeda Pharmaceutical、HeliCure、AstraZeneca、Ore Pharmaceuticals、Sihuan Pharmaceutical、GlaxoSmithKline、Pfizer、Abbott Laboratories、Yuhan Corporation、Cadila Healthcare、Boehringer Ingelheim

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗消化性潰瘍薬の世界市場2020-2026:プロトンポンプ阻害剤(PPI)、カリウム競合性酸遮断薬(P-CAB)、制酸薬、H2拮抗薬、抗生物質、潰瘍保護薬(Global Anti Peptic Ulcer Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。